Emerging Alliance

Recognizes new alliances (one to two years) that have already demonstrated corporate value and performance.

2024 - Jazz Pharmaceuticals and Sumitomo Pharmaceuticals
2023 - Novobird Hemophilia Gene Editing Alliance (Novo Nordisk and 2seventy bio)
2022 - Deloitte/Genpact Strategic Global Partnership
2021 - CRUK-iOnctura Alliance (Cancer Research UK and iOnctura)
2020 - Cancer Research UK and Bristol Myers Squibb
2019 - Akebia Therapeutics and Thermo Fisher Scientific
2019 - Merck and Sanofi Pasteur
2014 - Cisco and NetApp
2011 - Ipsen and Inspiration Pharmaceuticals | Hemophilia Drug Franchise
2011 - IBM and SAP
2010 - Novartis and Novartis Malaria Initiative
2009 - Autodesk and Citrix
2003 - Texas Instruments (Honorable mention: Cisco Systems)